386 related articles for article (PubMed ID: 21149767)
1. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
Chodick G; Shalev V
Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
[No Abstract] [Full Text] [Related]
2. Are statins effective in high-risk primary prevention?
Dentali F; Guasti L
Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
[No Abstract] [Full Text] [Related]
3. Statins and all-cause mortality in high-risk primary prevention of patients with cardiovascular risk factors.
Brugts JJ; Deckers JW
Arch Intern Med; 2010 Dec; 170(22):2041; author reply 2043-4. PubMed ID: 21149768
[No Abstract] [Full Text] [Related]
4. The JUPITER Trial: responding to the critics.
Ridker PM; Glynn RJ
Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
[No Abstract] [Full Text] [Related]
5. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
6. Lipid lowering for primary prevention.
Yusuf S; Lonn E; Bosch J
Lancet; 2009 Apr; 373(9670):1152-5. PubMed ID: 19345816
[No Abstract] [Full Text] [Related]
7. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
Ray KK; Seshasai SR; Erqou S; Sever P; Jukema JW; Ford I; Sattar N
Arch Intern Med; 2010 Jun; 170(12):1024-31. PubMed ID: 20585067
[TBL] [Abstract][Full Text] [Related]
8. Are we lowering LDL cholesterol sufficiently?
Barter P; Rye KA
Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
[No Abstract] [Full Text] [Related]
9. The numbers are in: statins for the primary prevention of cardiovascular disease in women.
Duvernoy CS; Blumenthal R
Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993
[No Abstract] [Full Text] [Related]
10. Cardiovascular primary prevention: how high should we set the bar?
Prasad V; Vandross A
Arch Intern Med; 2012 Apr; 172(8):656-9; discussion 659. PubMed ID: 22529231
[TBL] [Abstract][Full Text] [Related]
11. LDL-cholesterol differences predicted survival benefit in statin trials by the surrogate threshold effect (STE).
Johnson KR; Freemantle N; Anthony DM; Lassere MN
J Clin Epidemiol; 2009 Mar; 62(3):328-36. PubMed ID: 18834708
[TBL] [Abstract][Full Text] [Related]
12. Statins and hypertension.
Cífková R; Nilsson PM
J Hypertens; 2009 Mar; 27(3):662-5. PubMed ID: 19262236
[No Abstract] [Full Text] [Related]
13. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
Kones R
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
[TBL] [Abstract][Full Text] [Related]
14. The JUPITER trial: How will it change clinical practice?
Watson KE
Rev Cardiovasc Med; 2009; 10(2):91-6. PubMed ID: 19593321
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
Ridker PM;
Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
[No Abstract] [Full Text] [Related]
16. What do the statins tell us?
LaRosa JC
Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412
[TBL] [Abstract][Full Text] [Related]
17. [Primary prevention of cardiovascular diseases with statins in women].
Alici G; Karpuz V; Karpuz H
Turk Kardiyol Dern Ars; 2009 Jun; 37(4):273-80. PubMed ID: 19717964
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
Moyad MA; Merrick GS
Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
[TBL] [Abstract][Full Text] [Related]
19. [Primary and secondary prevention of coronary disease by statins].
Ferrières J
Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]